Get notified when SMTI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Immediate and Substantial Dilution of $33.31 Per Share (new) — New investors pay $41.39 per share but receive only $8.08 in net tangible book value, an immediate dilution of $33.31 per share.
  • Revenue Generated From the Sale of Scendia Products Is Heavily Dependent On License Agreements (new) — The company's Scendia revenue relies on non-exclusive license agreements with manufacturers that have terms of one to five years and may not be renewed.
  • Disruptions In the Supply of Tissues (new) — The company is currently experiencing tissue supply disruptions that are negatively impacting inventory of its ALLOCYTE product.
  • Earnout Consideration Is Payable In Cash Or, At Our Election, In Shares (new) — Up to $20.0 million in earnout payments may be settled in shares, causing further dilution to existing shareholders.
NASDAQ: SMTI Sanara MedTech Inc. 424B5

Sanara MedTech files to sell up to $75M of common stock at $41.39/share via Cantor Fitzgerald

Filed February 24, 2023 · ~1 min read

Key Changes

  • high

    Sanara MedTech may sell up to $75.0 million of common stock from time to time through Cantor Fitzgerald as sales agent, at an assumed price of $41.39 per share.

    The Offering verify on EDGAR →
  • medium

    The offering is primary only; proceeds go to the company. The filing does not specify a use of proceeds.

    Use of Proceeds verify on EDGAR →
  • high

    New investors face immediate dilution of $33.31 per share: they pay $41.39 but receive only $8.08 in net tangible book value per share.

    Dilution verify on EDGAR →

4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.

Partner

Trade SMTI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify